Sintx Technologies (SINT) Research & Development (2013 - 2026)
Sintx Technologies' (SINT) quarterly Research & Development came in at $399000.0 in Q1 2026, up 1895.0% year-on-year from $20000.0 in Q1 2025, and up 111.82% quarter-over-quarter from -$3.4 million in Q4 2025.
Sintx Technologies (SINT) Research & Development (2013 - 2026) Analysis & Trends
Sintx Technologies' Research & Development history runs 14 years deep, the most recent figure standing at $399000.0 for Q1 2026.
- On a quarterly basis, Research & Development rose 1895.0% year-over-year to $399000.0 in Q1 2026; TTM through Mar 2026 was -$475000.0, a 86.49% increase from a year earlier, with the FY2025 full-year figure at $242000.0, down 60.59% from the prior year.
- Research & Development advanced to $399000.0 in Q1 2026 per SINT's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Research & Development topped out at $5.4 million in Q4 2022 and bottomed at -$3.9 million in Q4 2024.
- The 5-year median for Research & Development is $310000.0 (2023), against an average of $541647.1.
- Across the five-year window, Research & Development slumped 1591.54% in 2024 and surged 1895.0% in 2026, its largest moves.
- Year by year, Research & Development stood at $5.4 million in 2022, then slumped by 95.21% to $260000.0 in 2023, then plunged by 1591.54% to -$3.9 million in 2024, then increased by 12.94% to -$3.4 million in 2025, then soared by 111.82% to $399000.0 in 2026.
- Per Business Quant, the three latest SINT Research & Development figures stand at $399000.0 (Q1 2026), -$3.4 million (Q4 2025), and $1.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 399,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 399,000.00 |
| Dec 31, 2025 | -3.38 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 246,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | 5.43 Mn |
| Sep 30, 2022 | 291,000.00 |
| Jun 30, 2022 | 338,000.00 |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.20 Mn |